Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through five segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems, BD Interventional, and BD Life Sciences. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery. Its Life Sciences segment includes diagnostic solutions and biosciences.
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for BDX. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: BDX is a Buy candidate.
BDX stock price ended at $144.18 on 星期三, after dropping 2.26%
On the latest trading day May 13, 2026, the stock price of BDX fell by 2.26%, dropping from $146.59 to $144.18. During the session, the stock saw a volatility of 2.63%, with prices oscillating between a daily low of $142.83 and a high of $146.59. On the latest trading day, the trading volume for BDX rose by 364.8K shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 3.8M shares were traded, with a market value of approximately $39.7B.
Các chỉ báo phân tích kỹ thuật áp dụng cho BDX như thế nào?
Theo phân tích kỹ thuật, Becton Dickinson and Co có tín hiệu tổng hợp là Sell. Becton Dickinson and Co có 2 tín hiệu mua, 1 tín hiệu trung tính và 4 tín hiệu bán.
Mức thoái lui Fibonacci cho BDX là bao nhiêu?
Mức thoái lui Fibonacci của Becton Dickinson and Co là 在 23.6% 和 38.2% 之间。
RSI của Becton Dickinson and Co là bao nhiêu?
RSI hiện tại của Becton Dickinson and Co là 40.83, cho thấy một điều kiện 中立
Giá của Becton Dickinson and Co trong 12 tháng tới là bao nhiêu?
Giá của Becton Dickinson and Co BDX trong 12 tháng tới được ước tính ở mức $0.
Becton Dickinson and Co dự kiến sẽ đạt đến mức nào?
Theo các nhà phân tích phố Wall, Becton Dickinson and Co dự kiến sẽ đạt đến mức cao $0.